Elizabeth Berry-Kravis to Phosphodiesterase 4 Inhibitors
This is a "connection" page, showing publications Elizabeth Berry-Kravis has written about Phosphodiesterase 4 Inhibitors.
Connection Strength
0.774
-
Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial. Nat Med. 2021 05; 27(5):862-870.
Score: 0.774
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.